Page last updated: 2024-10-24

chloroquine and Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia

chloroquine has been researched along with Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wehrmann, ZT1
Hulett, TW1
Huegel, KL1
Vaughan, KT1
Wiest, O1
Helquist, P1
Goodson, H1

Other Studies

1 other study available for chloroquine and Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia

ArticleYear
Quantitative comparison of the efficacy of various compounds in lowering intracellular cholesterol levels in Niemann-Pick type C fibroblasts.
    PloS one, 2012, Volume: 7, Issue:10

    Topics: Azacitidine; beta-Cyclodextrins; Cells, Cultured; Child; Child, Preschool; Chloroquine; Chlorpromazi

2012